Does RISANKIZUMAB-RZAA Cause Device difficult to use? 60 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Device difficult to use have been filed in association with RISANKIZUMAB-RZAA. This represents 0.1% of all adverse event reports for RISANKIZUMAB-RZAA.
60
Reports of Device difficult to use with RISANKIZUMAB-RZAA
0.1%
of all RISANKIZUMAB-RZAA reports
0
Deaths
3
Hospitalizations
How Dangerous Is Device difficult to use From RISANKIZUMAB-RZAA?
Of the 60 reports, 3 (5.0%) required hospitalization.
Is Device difficult to use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 60 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Device difficult to use?
EVOLOCUMAB (31,807)
ERENUMAB-AOOE (9,530)
ETONOGESTREL (3,799)
ETANERCEPT (2,746)
LEVONORGESTREL (2,695)
SOMATROPIN (1,263)
ADALIMUMAB (507)
LEVODOPA (466)
NEXPLANON (425)
CARBIDOPA\LEVODOPA (424)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Device difficult to use Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA